Michael Carleton

6.1k total citations · 1 hit paper
37 papers, 3.4k citations indexed

About

Michael Carleton is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Michael Carleton has authored 37 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Michael Carleton's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and MicroRNA in disease regulation (6 papers). Michael Carleton is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and MicroRNA in disease regulation (6 papers). Michael Carleton collaborates with scholars based in United States, Spain and Italy. Michael Carleton's co-authors include Peter S. Linsley, Michele A. Cleary, David L. Wiest, Janell M. Schelter, Aimee L. Jackson, Mariëlle C. Haks, Michele Rhodes, Solmaz Sahebjam, John H. Sampson and Antonio Omuro and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and The Journal of Immunology.

In The Last Decade

Michael Carleton

36 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

2020 946 citations David A. Reardon, Alba A. Brandes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Carleton United States	22	1.8k	1.3k	1.0k	817	690	37	3.4k
Jeffrey L. Kutok United States	16	1.8k 1.0×	1.1k 0.9×	1.2k 1.1×	640 0.8×	518 0.8×	26	3.6k
Grant A. Challen United States	31	2.8k 1.6×	712 0.6×	1.2k 1.1×	633 0.8×	1.1k 1.6×	76	5.1k
Karim Y. Helmy United States	18	848 0.5×	464 0.4×	859 0.8×	407 0.5×	727 1.1×	20	2.2k
Yoko Oei United States	12	1.4k 0.8×	338 0.3×	1.9k 1.9×	1.1k 1.3×	541 0.8×	17	3.6k
Timothy P. Bender United States	29	2.3k 1.3×	1.1k 0.9×	1.4k 1.4×	744 0.9×	329 0.5×	63	4.0k
Youmna Kfoury United States	25	980 0.5×	342 0.3×	1.0k 1.0×	537 0.7×	510 0.7×	42	2.5k
Dalong Qian United States	16	3.6k 2.0×	1.6k 1.3×	646 0.6×	2.2k 2.6×	325 0.5×	30	5.4k
Marieke von Lindern Netherlands	43	3.9k 2.2×	699 0.6×	618 0.6×	633 0.8×	884 1.3×	134	5.7k
Yiping He United States	25	3.1k 1.7×	1.4k 1.1×	398 0.4×	556 0.7×	210 0.3×	70	4.4k
Naohiko Koshikawa Japan	40	2.1k 1.1×	2.1k 1.7×	438 0.4×	1.6k 2.0×	405 0.6×	102	4.9k

Countries citing papers authored by Michael Carleton

Since Specialization

Citations

This map shows the geographic impact of Michael Carleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Carleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Carleton more than expected).

Fields of papers citing papers by Michael Carleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Carleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Carleton. The network helps show where Michael Carleton may publish in the future.

Co-authorship network of co-authors of Michael Carleton

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Carleton. A scholar is included among the top collaborators of Michael Carleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Carleton. Michael Carleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahipal, Amit, Patricia LoRusso, Renate Schneider, et al.. (2024). 348 (PB336): ATRN-119, a Novel Macrocyclic ATR Inhibitor, in Patients with Advanced Solid Malignancies: A Phase 1/2a Trial (ABOYA-119). European Journal of Cancer. 211. 114861–114861.

Lim, Michael, Antonio Omuro, Gordana Vlahovic, et al.. (2017). Nivolumab (nivo) in combination with radiotherapy (RT) ± temozolomide (TMZ): Updated safety results from CheckMate 143 in pts with methylated or unmethylated newly diagnosed glioblastoma (GBM). Annals of Oncology. 28. v109–v109. 18 indexed citations

Dey, Joyoti, William Kerwin, Marc Grenley, et al.. (2016). A Platform for Rapid, Quantitative Assessment of Multiple Drug Combinations Simultaneously in Solid Tumors In Vivo. PLoS ONE. 11(6). e0158617–e0158617. 6 indexed citations

Chen, Nianhang, Carrie Baker Brachmann, Xiping Liu, et al.. (2015). Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration. Cancer Chemotherapy and Pharmacology. 76(4). 699–712. 89 indexed citations

Lee, Sang-Yun, Francis Coffey, Shawn P. Fahl, et al.. (2014). Noncanonical Mode of ERK Action Controls Alternative αβ and γδ T Cell Lineage Fates. Immunity. 41(6). 934–946. 25 indexed citations

Kaiser, Brett K., Michael Carleton, Jason W. Hickman, et al.. (2013). Fatty Aldehydes in Cyanobacteria Are a Metabolically Flexible Precursor for a Diversity of Biofuel Products. PLoS ONE. 8(3). e58307–e58307. 53 indexed citations

Warrener, Paul, Sybil M. Genther Williams, Matthew C. Biery, et al.. (2012). Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ. APOPTOSIS. 17(7). 691–701. 7 indexed citations

Stec, Erica, Louis Locco, Steven R. Bartz, et al.. (2012). A Multiplexed siRNA Screening Strategy to Identify Genes in the PARP Pathway. SLAS DISCOVERY. 17(10). 1316–1328. 6 indexed citations

Zhang, Zhan, Hong Sun, Hongyue Dai, et al.. (2009). MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle. 8(17). 2756–2768. 236 indexed citations

10.

Georges, Sara A., Matthew C. Biery, Soo‐Yeon Kim, et al.. (2008). Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Research. 68(24). 10105–10112. 286 indexed citations

11.

Carleton, Michael, Michele A. Cleary, & Peter S. Linsley. (2007). MicroRNAs and Cell Cycle Regulation. Cell Cycle. 6(17). 2127–2132. 285 indexed citations

12.

Carleton, Michael, Mao Mao, Matthew C. Biery, et al.. (2006). RNA Interference-Mediated Silencing of Mitotic Kinesin KIF14 Disrupts Cell Cycle Progression and Induces Cytokinesis Failure. Molecular and Cellular Biology. 26(10). 3853–3863. 100 indexed citations

13.

Haks, Mariëlle C., Juliette M. Lefebvre, Jens Peter H. Lauritsen, et al.. (2005). Attenuation of γδTCR Signaling Efficiently Diverts Thymocytes to the αβ Lineage. Immunity. 22(5). 595–606. 192 indexed citations

14.

Lefebvre, Juliette M., Mariëlle C. Haks, Michael Carleton, et al.. (2005). Enforced Expression of Spi-B Reverses T Lineage Commitment and Blocks β-Selection. The Journal of Immunology. 174(10). 6184–6194. 47 indexed citations

15.

Radich, Jerald P., Mao Mao, S. Stepaniants, et al.. (2004). Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics. 83(6). 980–988. 106 indexed citations

16.

Carleton, Michael, Mariëlle C. Haks, Allan R. Jones, et al.. (2002). Early Growth Response Transcription Factors Are Required for Development of CD4−CD8− Thymocytes to the CD4+CD8+ Stage. The Journal of Immunology. 168(4). 1649–1658. 80 indexed citations

17.

Berger, Marc A., Michael Carleton, Michele Rhodes, et al.. (2000). Identification of a novel pre-TCR isoform in which the accessibility of the TCRβ subunit is determined by occupancy of the `missing' V domain of pre-Tα. International Immunology. 12(11). 1579–1591. 4 indexed citations

18.

Kruisbeek, Ada M., Mariëlle C. Haks, Michael Carleton, et al.. (2000). Branching out to gain control: how the pre-TCR is linked to multiple functions. Immunology Today. 21(12). 637–644. 99 indexed citations

19.

Wiest, David L. & Michael Carleton. (1999). Control of early thymocyte development by the pre-T cell receptor complex: A receptor without a ligand?. Seminars in Immunology. 11(4). 251–262. 36 indexed citations

20.

Carleton, Michael, Hyun O. Lee, Matthew A. Mulvey, & Dennis T. Brown. (1997). Role of glycoprotein PE2 in formation and maturation of the Sindbis virus spike. Journal of Virology. 71(2). 1558–1566. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact